Akouos, Inc.
AKUSDelisted Dec 1, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001722271
Akouos, Inc. was delisted on Dec 1, 2022; its insiders filed their last Form 4 on Dec 2, 2022; 64 institutions reported holding it in 13F filings for Q3 2022, worth $241.2M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Akouos, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Akouos, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| New Enterprise Associates 16, L.P. | 10% Owner | 0 | Dec 2, 2022 | 0 |
| NEA Partners 16, L.P. | 10% Owner | 0 | Dec 2, 2022 | 0 |
| Nea 16 GP, LLC | 10% Owner | 0 | Dec 2, 2022 | 0 |
| Rocklage Scott M | 10% Owner | 0Indirect | Dec 2, 2022 | 0 |
| Schwab Andrew J. | 10% Owner | 0Indirect | Dec 2, 2022 | 0 |
| 5AM Ventures V, L.P. | 10% Owner | 0Indirect | Dec 2, 2022 | 0 |
| 5AM Opportunities I, L.P. | 10% Owner | 0Indirect | Dec 2, 2022 | 0 |
| 5AM Opportunities I (GP), LLC | 10% Owner | 0Indirect | Dec 2, 2022 | 0 |
| 5AM Partners V, LLC | 10% Owner | 0Indirect | Dec 2, 2022 | 0 |
| Sato Vicki L | Director | – | Dec 2, 2022 | 0 |
| Sandell Scott D | 10% Owner | 0Indirect | Dec 2, 2022 | 0 |
| Baskett Forest | 10% Owner | 0Indirect | Dec 2, 2022 | 0 |
| Mathers Edward T | Director | – | Dec 2, 2022 | 0 |
| Ramasastry Saira | Director | – | Dec 2, 2022 | 0 |
| Walker Paul Edward | 10% Owner | 0Indirect | Dec 2, 2022 | 0 |
| Sonsini Peter W. | 10% Owner | 0Indirect | Dec 2, 2022 | 0 |
| Florence Anthony A. Jr. | 10% Owner | 0Indirect | Dec 2, 2022 | 0 |
| Tzianabos Arthur | Director | 0 | Dec 2, 2022 | 0 |
| Preston Heather | Director | 0 | Dec 2, 2022 | 0 |
| Behbahani Ali | 10% Owner | 0Indirect | Dec 2, 2022 | 0 |
| Makhzoumi Mohamad | 10% Owner | 0Indirect | Dec 2, 2022 | 0 |
| Parmar Kush | Director, 10% Owner | 0Indirect | Dec 2, 2022 | 0 |
| Chang Carmen | 10% Owner | 0Indirect | Dec 2, 2022 | 0 |
| McKenna Michael John | Chief Medical Officer | 0 | Dec 2, 2022 | 0 |
| Simons Emmanuel | Chief Executive Officer | 0 | Dec 2, 2022 | 0 |
| Minegishi Sachiyo | Chief Financial Officer | – | Dec 2, 2022 | 0 |
| Wellman Jennifer Anne | CHIEF OPERATING OFFICER | 0 | Dec 2, 2022 | 0 |
| Eli Lilly & Co | 10% Owner | 100 | Dec 1, 2022 | 0 |
| Kearny Acquisition Corp | 10% Owner | 100 | Dec 1, 2022 | 0 |
| Smith Christopher M | Director | – | Jun 27, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 (view filing)4:10 PM ET | Nov 30 | 1 day | Eli Lilly & Co and 1 other10% Owner | PPurchase | +30.0M | $12.50 | +$374.9M | New position100 after |